My NCBISign In

Display Settings:

Format

Send to:

Choose Destination
    Clin J Pain. 1998 Dec;14(4):320-3.

    Percutaneous electrical nerve stimulation (PENS): a complementary therapy for the management of pain secondary to bony metastasis.

    Ahmed HE, Craig WF, White PF, Huber P.

    Source

    Department of Anesthesiology and Pain Management, Eugene McDermott Center for Pain Management, University of Texas Southwestern Medical Center at Dallas, 75235-9068, USA.

    Abstract

    OBJECTIVE:

    To evaluate the use of a novel nonpharmacologic analgesic therapy known as percutaneous electrical nerve stimulation (PENS) in the management of opioid-resistant cancer pain.

    DESIGN:

    PENS therapy was administered to three cancer patients on three or more occasion using acupuncturelike needle probes that were stimulated for 30 minutes at frequencies of 4-100 Hz.

    RESULTS:

    Two of the three patients achieved good to excellent pain relief that lasted 24-72 hours after each treatment session.

    CONCLUSION:

    PENS therapy is a useful supplement to opioid analgesics for the management of pain secondary to bony metastasis in terminal cancer patients.

    PMID:
    9874011
    [PubMed - indexed for MEDLINE]

    Publication Types, MeSH Terms, Substances

    Publication Types

    MeSH Terms

    Substances

    LinkOut - more resources

    Full Text Sources

    Other Literature Sources

    Education

    Medical

      Supplemental Content

      Save items

      loading

      Related citations in PubMed

      See reviews... See all...

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk